The description of the invention patent does make specific reference to the use of Novosorb BTM in the examples provided, and also references the PolyNovo patents.
But the patent claims are not limited to just a biodegradable polyurethane matrix scaffold.
Also claimed is use of a matrix comprising
one or more of a polyurethane, a collagen, a glycosaminoglycan, a collagen-GAG co-polymer and/or mixture, a mucopolysaccharide, a poly(alpha-hydroxy acid), a poly(lactic acid) and/or a structural isomer thereof, a polyglycolic acid and/or a structural isomer thereof, a chitosan, a polylactic-polyglycolic polymer, and a polycaprolactone.
Ann: BTM delivers positive First in Man results in Cell Therapies, page-130
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.22 |
Change
0.015(1.24%) |
Mkt cap ! $842.8M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.22 | $1.19 | $2.606M | 2.146M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 37701 | $1.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 102533 | 4 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PNV (ASX) Chart |